Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study - Emiel A. De Jaeghere; Sandra Tuyaerts; An M. T. Van Nufel; Ann Belmans; Kris Bogaerts; Regina Baiden-Amissah; Lien Lippens; Peter Vuylsteke; Stéphanie Henry; Xuan Bich Trinh; Peter A. van Dam; Sandrine Aspeslagh; et al. (Cancer Immunology, Immunotherapy)